HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antithrombin III Deficiency

An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
Also Known As:
Antithrombin 3 Deficiency; Deficiency, Antithrombin III; Antithrombin 3 Deficiencies; Antithrombin III Deficiencies; Deficiencies, Antithrombin 3; Deficiencies, Antithrombin III; Deficiency, Antithrombin 3
Networked: 265 relevant articles (4 outcomes, 11 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Thrombosis (Thrombus)
2. Thrombocytopenia (Thrombopenia)
3. Protein S Deficiency (Deficiency, Protein S)
4. Thrombophilia
5. Protein C Deficiency

Experts

1. Liu, Junli: 2 articles (12/2006 - 03/2005)
2. Gurgey, A: 2 articles (01/2006 - 03/2001)
3. Gunaydin, Serdar: 1 article (01/2015)
4. Özdemir, Hasan H: 1 article (01/2015)
5. Acar, Abdullah: 1 article (01/2015)
6. Liu, Jui-Chen: 1 article (01/2015)
7. Hsu, Yi-Ting: 1 article (01/2015)
8. Varol, Sefer: 1 article (01/2015)
9. Demir, Caner F: 1 article (01/2015)
10. Huang, Hung Yu: 1 article (01/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Antithrombin III Deficiency:
1. Antithrombin IIIIBA
2. Heparin (Liquaemin)FDA LinkGeneric
3. argatroban (MPQA)FDA Link
4. Ancrod (Arvin)IBA
5. Protein CIBA
6. Protein SIBA
7. factor V LeidenIBA
8. Prothrombin (Factor II)IBA
9. Anticardiolipin AntibodiesIBA
09/27/2001 - "Are ESRD patients with hypercoagulable states (HCS) (antithrombin III deficiency, protein S or C deficiency, activated protein C resistance, and anticardiolipin antibodies) at predictably greater risk for allograft thrombosis? "
10/01/1997 - "The pathophysiological basis of blood coagulation includes hemostatic causes and thrombophilia (protein C deficiency, protein S deficiency, APC resistance, plasminogen deficiency, antithrombin III deficiency, hyperhomocystinemia, lupus anticoagulans and anticardiolipin antibodies). "
08/28/1997 - "Investigation for a hypercoagulable state revealed activated protein C resistance in the absence of protein C, protein S, or antithrombin III deficiency or anticardiolipin antibodies. "
08/01/2000 - "Studies looking at the prevalence of specific thrombophilic states such as Antithrombin III deficiency (Jackson et al. 1997; Lake, Stauffer & Stuart 1978; Cianco et al. 1996; Ghosh et al. 1983), Factor V Leiden mutation (APC Resistance) (Jackson et al. 1997; Probert et al. 1997; Ardizzone et al. 1998; Liebman et al. 1998), anticardiolipin antibodies (Ciancio et al. 1996), Protein C (Wyshock, Caldwell & Crowley 1988; Korsten & Reis 1992) and Protein S deficiencies (Jorens et al. 1990; Aadland et al. 1992) in IBD have been contradictory or equivocal. "
12/01/2008 - "These women were tested for inherited and/or acquired thrombophilia by MTHFR C677T gene polymorphism, factor V Leiden gene polymorphism, PTHRA20210G gene polymorphism, protein S deficiency, protein C deficiency, antithrombin III deficiency, lupus anticoagulant, and anticardiolipin antibodies Ig G and Ig M. "
10. ThrombinFDA Link

Therapies and Procedures

1. Cardiopulmonary Bypass (Heart-Lung Bypass)
2. Critical Care
3. Transplants (Transplant)
4. Renal Dialysis (Hemodialysis)
5. Catheters